CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $10.42 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.